HIV/AIDS Awareness Days

HIV Vaccine Awareness Day

May 18, 2017

In 1987, the first HIV vaccine clinical trial opened at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Thirty years later research continues to realize the promise of safe and effective HIV vaccines. HIV Vaccine Awareness Day is an occasion to recognize and support the efforts of countless individuals and organizations—past and present—involved in HIV vaccine research.

HIV research includes studies of both preventive and therapeutic vaccines:
  • Preventive HIV vaccines are intended to prevent HIV infection in people who are not infected with HIV. A safe and effective preventive HIV vaccine is key to ending the HIV/AIDS pandemic.
  • Therapeutic HIV vaccines are designed to treat people who are infected with HIV. A safe and effective therapeutic HIV vaccine could prevent HIV from advancing to AIDS, replace daily use of HIV medicines, and help rid the body of HIV.
  • To learn more, read the AIDSinfo fact sheets What is a Preventive HIV Vaccine? and What is a Therapeutic HIV Vaccine?
Browse the links on this page to learn more about HIV Vaccine Awareness Day and the progress of HIV vaccine research.

The U.S. Government Observes HIV Vaccine Awareness Day

HIV Vaccine Awareness Day Webpages

HIV Vaccine Research

FY 2018 Trans-NIH Plan for HIV-Related Research, from the National Institutes of Health (NIH) Office of AIDS Research (OAR): The Plan outlining the NIH HIV/AIDS research agenda for 2018 includes HIV vaccine research.

Clinical Trials About HIV Vaccines

From the AIDSinfo clinical trials search tool:
Call AIDSinfo at 1-800-448-0440 for help finding clinical trials about HIV vaccine research.

Published Research About HIV Vaccines
From the Education Resources Information Center (ERIC):

Additional Information About HIV Vaccines

From the HIV Vaccine Trials Network (HVTN)
From AIDSinfo
From NLM AIDSource
Email News letter Updates